Incontinence Center At Englewood Hosp is categorized under Hospitals in Englewood, NJ and active since 1994.
Incontinence Center At Englewood Hosp was established in 1994, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Mike Petrowitz at the company’s single location by writing to 350 Engle St, Englewood, New Jersey NJ 07631 or by phoning (215) 698-5900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Incontinence Center At Englewood Hosp |
Contact Person: | Mike Petrowitz |
Address: | 350 Engle St, Englewood, New Jersey 07631 |
Phone Number: | (215) 698-5900 |
Website Address: | englewoodhospital.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1994 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hospitals |
SIC Code: | 8062 |
NAICS Code: | 622110 |
Share This Business: |
Incontinence Center At Englewood Hosp was started in 1994 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mike Petrowitz for inquiries that concern Incontinence Center At Englewood Hosp by calling the company number (215) 698-5900, as your correspondence is most welcome. Additionally, the physical location of the single location of Incontinence Center At Englewood Hosp can be found at the coordinates 40.904845,-73.967194 as well as the street address 350 Engle St in Englewood, New Jersey 07631.
For its online presence, you may visit Incontinence Center At Englewood Hosp’s website at englewoodhospital.com and engage with its social media outlets through on Twitter and on Facebook.